IBCSG2200_2A: IBCSG2200, figure 2A

IBCSG2200_2AR Documentation

IBCSG2200, figure 2A

Description

Kaplan-Meier digitized data from IBCSG2200, figure 2A (PMID 27325862). A reported sample size of 1,086 for a primary endpoint of DFS in breast cancer.

Usage

IBCSG2200_2A

Format

A data frame of 1,081 observations and 3 variables:

time event time (in years)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (cm, no cm)

Source

Colleoni M, Gray KP, Gelber S, et al. Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00. J Clin Oncol 2016; 34: 3400–8.

Examples

summary(IBCSG2200_2A)

kmplot(IBCSG2200_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.